Gragoudas; Evangelos S.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Gragoudas; Evangelos S..The latest application filed is for "methods and compositions for treating conditions of the eye".
Company Profile
1.13.35
- Gragoudas; Evangelos S. - Lexington MA
- Gragoudas; Evangelos S. - Cambridge MA
- Gragoudas; Evangelos S. - Boston MA
Patent Activity
| Patent | Date |
|---|---|
| Methods and compositions for treating ocular glaucoma Grant 10,272,261 - Miller , et al. | 2019-04-30 |
| Methods and Compositions for Treating Conditions of the Eye App 20180369380 - Gragoudas; Evangelos S. ; et al. | 2018-12-27 |
| Treatment Of Ocular Disorders App 20170354671 - Iliaki; Eirini ; et al. | 2017-12-14 |
| Treatment of ocular disorders Grant 9,572,829 - Iliaki , et al. February 21, 2 | 2017-02-21 |
| Methods and Compositions for Treating Conditions of the Eye App 20170035883 - Gragoudas; Evangelos S. ; et al. | 2017-02-09 |
| Drug Delivery Systems and Use Thereof App 20160143844 - Carrasquillo; Karen G. ; et al. | 2016-05-26 |
| Methods And Compositions For Treating Ocular Glaucoma App 20160016000 - Miller; Joan W. ; et al. | 2016-01-21 |
| Treatment Of Ocular Disorders App 20160000817 - Iliaki; Eirini ; et al. | 2016-01-07 |
| Treatment of ocular disorders Grant 8,987,219 - Iliaki , et al. March 24, 2 | 2015-03-24 |
| Drug Delivery Systems and Use Thereof App 20140328937 - Carrasquillo; Karen G. ; et al. | 2014-11-06 |
| Methods and Compositions for Treating Conditions of the Eye App 20140178407 - Gragoudas; Evangelos S. ; et al. | 2014-06-26 |
| Methods and Compositions for Treating Conditions of the Eye App 20140163451 - Miller; Joan W. ; et al. | 2014-06-12 |
| Methods and compositions for treating conditions of the eye Grant 8,658,633 - Poulaki , et al. February 25, 2 | 2014-02-25 |
| Drug Delivery Systems And Use Thereof App 20130209570 - Carrasquillo; Karen G. ; et al. | 2013-08-15 |
| Use Of Green Porphyrins To Treat Neovasculature In The Eye App 20130072849 - Miller; Joan W. ; et al. | 2013-03-21 |
| Methods and Compositions for Treating Conditions of the Eye App 20120323162 - Miller; Joan W. ; et al. | 2012-12-20 |
| Drug Delivery Systems and Use Thereof App 20120201859 - Carrasquillo; Karen G. ; et al. | 2012-08-09 |
| Methods and Compositions for Treating Conditions of the Eye App 20110189191 - GRAGOUDAS; EVANGELOS S. ; et al. | 2011-08-04 |
| Methods and Compositions for Treating Conditions of the Eye App 20110144035 - MILLER; JOAN W. ; et al. | 2011-06-16 |
| Use of Green Porphyrins to Treat Neovasculature in the Eye App 20110137228 - Miller; Joan W. ; et al. | 2011-06-09 |
| Methods and compositions for treating conditions of the eye Grant 7,803,375 - Gragoudas , et al. September 28, 2 | 2010-09-28 |
| Drug Delivery Systems and Use Thereof App 20100189801 - Carrasquillo; Karen G. ; et al. | 2010-07-29 |
| Methods and Compositions for Treating Conditions of the Eye App 20090286743 - Miller; Joan W. ; et al. | 2009-11-19 |
| Implantable drug delivery device and use thereof Grant 7,563,255 - Adamis , et al. July 21, 2 | 2009-07-21 |
| Use of green porphyrins to treat neovasculature in the eye App 20080241232 - Miller; Joan W. ; et al. | 2008-10-02 |
| Treatment of ocular disorders Grant 7,419,666 - Iliaki , et al. September 2, 2 | 2008-09-02 |
| Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage App 20070248646 - Hafezi-Moghadam; Ali ; et al. | 2007-10-25 |
| Methods and compositions for treating conditions of the eye App 20070191917 - Poulaki; Vassiliki ; et al. | 2007-08-16 |
| Use of green porphyrins to treat neovasculature in the eye App 20070087046 - Miller; Joan W. ; et al. | 2007-04-19 |
| Methods and compositions for treating conditions of the eye Grant 7,125,542 - Miller , et al. October 24, 2 | 2006-10-24 |
| Methods and compositions for treating conditions of the eye App 20060204504 - Gragoudas; Evangelos S. ; et al. | 2006-09-14 |
| Transscleral drug delivery device and related methods App 20060167435 - Adamis; Anthony P. ; et al. | 2006-07-27 |
| Methods and compositions for treating ocular glaucoma App 20060021623 - Miller; Joan W. ; et al. | 2006-02-02 |
| Targeted transscleral controlled release drug delivery to the retina and choroid App 20050208103 - Adamis, Anthony P. ; et al. | 2005-09-22 |
| Drug delivery systems and use thereof App 20050175708 - Carrasquillo, Karen G. ; et al. | 2005-08-11 |
| Use of green porphyrins to treat neovasculature in the eye App 20050152960 - Miller, Joan W. ; et al. | 2005-07-14 |
| Use of green porphyrins to treat neovasculature in the eye App 20040034007 - Miller, Joan W. ; et al. | 2004-02-19 |
| Methods and compositions for treating conditions of the eye App 20030185834 - Miller, Joan W. ; et al. | 2003-10-02 |
| Methods and compositions for treating conditions of the eye App 20030175282 - Miller, Joan W. ; et al. | 2003-09-18 |
| Use of green porphyrins to treat neovasculature in the eye Grant 6,610,679 - Miller , et al. August 26, 2 | 2003-08-26 |
| Implantable drug delivery device and use thereof App 20030069560 - Adamis, Anthony P. ; et al. | 2003-04-10 |
| Methods and compositions for treating conditions of the eye App 20020040015 - Miller, Joan W. ; et al. | 2002-04-04 |
| Use of green porphyrins to treat neovasculature in the eye App 20010023247 - Miller, Joan W. ; et al. | 2001-09-20 |
| Use of green porphyrins to treat neovasculature in the eye Grant 6,225,303 - Miller , et al. May 1, 2 | 2001-05-01 |
| Angiographic method using green porphyrins in primate eyes Grant 5,707,986 - Miller , et al. January 13, 1 | 1998-01-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 